Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bristol Myers Squibb Company BMY

Healthcare  —  Drug Manufacturers General
62.86 1.36 2.21% as of 25 Sep
Market cap
$125.9B
P/E
13.8×
S&P 500 Member Dividend Aristocrat
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bristol Myers Squibb Company (BMY) Return on invested capital

Bristol Myers Squibb Company's return on invested capital over the twelve months to 30 June 2026 was 13.7%, up 2.7 percentage points from fiscal 2025 (11.0%). Over the past ten years it has ranged from −9.49% (fiscal 2024) to 29.3% (fiscal 2018); the current reading is higher than 73% of that period. That is above the Drug Manufacturers General industry median of 6.30% and above the Healthcare sector median of 0.00%.

Return on invested capital, annual

Annual

Period Return on invested capital Change (points)
FY2025 11.0% 20.50
FY2024 −9.49% (18.75)
FY2023 9.26% 1.38
FY2022 7.88% (0.08)
FY2021 7.96% 13.86
FY2020 −5.90% (9.64)
FY2019 3.74% (25.59)
FY2018 29.3% 4.66
FY2017 24.7% 2.54
FY2016 22.1% 14.42

Against its own ten years

Low −9.49% High 29.3%
Ten-year median 7.96%
Current reading's percentile 73

Return on invested capital against peers

Company Return on invested capital
NVO Novo Nordisk A/S compare 28.7%
BMY Bristol Myers Squibb Company 13.7%
NVS Novartis AG compare 13.1%
AMGN Amgen Inc. compare 13.0%
GSK GSK PLC Sponsored ADR compare 12.6%
AZN AstraZeneca PLC compare 11.7%
SNY Sanofi compare 6.58%
PFE Pfizer Inc. compare 6.30%
GILD Gilead Sciences, Inc. compare −4.48%
Drug Manufacturers General industry median 6.30%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on BMY